Select Publications
Journal articles
2015, 'Riociguat for the treatment of pulmonary arterial hypertension: A long-term extension study (patent-2)', European Respiratory Journal, 45, pp. 1303 - 1313, http://dx.doi.org/10.1183/09031936.00090614
,2015, 'Percutaneous intervention to large left anterior descending artery fistula post-right ventricular biopsy in a transplant recipient', JACC: Cardiovascular Interventions, 8, pp. e81 - e82, http://dx.doi.org/10.1016/j.jcin.2014.11.029
,2015, 'Effect of exercise and pump speed modulation on invasive hemodynamics in patients with centrifugal continuous-flow left ventricular assist devices', Journal of Heart and Lung Transplantation, 34, pp. 522 - 529, http://dx.doi.org/10.1016/j.healun.2014.11.004
,2015, 'Modified Potts shunt in an adult with pulmonary arterial hypertension and recurrent syncope - Three-year follow-up', International Journal of Cardiology, 182, pp. 36 - 37, http://dx.doi.org/10.1016/j.ijcard.2015.01.009
,2015, 'Use of clinically relevant responder threshold criteria to evaluate the response to treatment in the Phase III PATENT-1 study', Journal of Heart and Lung Transplantation, 34, pp. 338 - 347, http://dx.doi.org/10.1016/j.healun.2014.12.001
,2015, 'Riociguat zur Behandlung der pulmonal arteriellen Hypertonie (PAH): 2-Jahres-Ergebnisse aus der Folgestudie zur Langzeitbeobachtung PATENT-2', Pneumologie, 69, http://dx.doi.org/10.1055/s-0035-1544810
,2015, 'Native T1 myocardial tissue characterisation in patients with pulmonary hypertension: Findings from International T1 Multicentre Study', Journal of Cardiovascular Magnetic Resonance, pp. 1 - 2, http://dx.doi.org/10.1186/1532-429X-17-S1-O32
,2015, 'Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease', Science Translational Medicine, 7, http://dx.doi.org/10.1126/scitranslmed.3010134
,2015, 'Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors', Journal of Heart and Lung Transplantation, 34, pp. 1406 - 1414, http://dx.doi.org/10.1016/j.healun.2015.05.021
,2015, 'Dental-associated viridans streptococci bloodstream infection in patients with continuous-flow ventricular assist devices', Heart, Lung and Circulation, 24, pp. S202 - S202, http://dx.doi.org/10.1016/j.hlc.2015.06.215
,2015, 'Disagreement between thermodilution and indirect Fick cardiac outputs in a mixed pulmonary hypertension and heart failure population', Heart, Lung and Circulation, 24, pp. S203 - S203, http://dx.doi.org/10.1016/j.hlc.2015.06.218
,2015, 'Effect of exercise and pump speed modulation on invasive hemodynamics in patients with centrifugal continuous-flow left ventricular assist devices', Journal of Heart and Lung Transplantation, http://dx.doi.org/10.1016/j.healun.2014.11.004
,2015, 'Impact of either short- or long-term right heart support on continuous flow LVAD outcomes', Heart, Lung and Circulation, 24, pp. S208 - S208, http://dx.doi.org/10.1016/j.hlc.2015.06.230
,2015, 'Myocardial tissue characterisation by Cardiovascular Magnetic Resonance diagnoses and tracks recovery after cardiac transplant rejection', Heart, Lung and Circulation, 24, pp. S386 - S387, http://dx.doi.org/10.1016/j.hlc.2015.06.639
,2015, 'Potential role of coenzyme Q10 in facilitating recovery from statin-induced rhabdomyolysis.', Intern Med J, 45, pp. 451 - 453, http://dx.doi.org/10.1111/imj.12712
,2015, 'Prognostic value of multislice computed tomography coronary angiography (CTCA) in cardiac transplant vasculopathy', Heart, Lung and Circulation, 24, pp. S356 - S357, http://dx.doi.org/10.1016/j.hlc.2015.06.572
,2014, 'Primary Graft Dysfunction After Heart Transplantation', Current Transplantation Reports, 1, pp. 257 - 265, http://dx.doi.org/10.1007/s40472-014-0033-6
,2014, 'Normalisation of haemodynamics in patients with end-stage heart failure with continuous-flow left ventricular assist device therapy', Heart Lung and Circulation, 23, pp. 963 - 969, http://dx.doi.org/10.1016/j.hlc.2014.04.259
,2014, 'Contractile dysfunction of left ventricular cardiomyocytes in patients with pulmonary arterial hypertension', Journal of the American College of Cardiology, 64, pp. 28 - 37, http://dx.doi.org/10.1016/j.jacc.2014.04.031
,2014, 'Imatinib for the treatment of pulmonary arterial hypertension and pulmonary capillary hemangiomatosis', Pulmonary Circulation, 4, pp. 342 - 345, http://dx.doi.org/10.1086/675996
,2014, 'Percutaneous interventional therapies for the treatment of patients with severe pulmonary hypertension', Journal of the American College of Cardiology, 63, pp. 611 - 618, http://dx.doi.org/10.1016/j.jacc.2013.11.022
,2014, 'Korrelation der hämodynamischen Verbesserung mit der körperlichen Leistungsfähigkeit bei Patienten mit PAH: Ergebnisse der Phase-III-Studie PATENT-1', Pneumologie, 68, http://dx.doi.org/10.1055/s-0034-1368073
,2014, 'Riociguat zur Behandlung der pulmonal arteriellen Hypertonie (PAH): eine Responder-Analyse aus der Phase-III-Studie PATENT-1', Pneumologie, 68, http://dx.doi.org/10.1055/s-0034-1368081
,2014, 'Pulmonary hypertension and breathlessness: Is it a combination we can ignore?', Internal Medicine Journal, 44, pp. 114 - 123, http://dx.doi.org/10.1111/imj.12321
,2014, 'Body Position and Activity, But Not Heart Rate, Affect Pump Flows in Patients With Continuous-Flow Left Ventricular Assist Devices', JACC: Heart Failure, 2, pp. 323 - 330, http://dx.doi.org/10.1016/j.jchf.2014.02.008
,2014, 'Cardiac surgery is successful in heart transplant recipients', Heart Lung and Circulation, 23, pp. 703 - 710, http://dx.doi.org/10.1016/j.hlc.2014.03.003
,2014, 'Six-minute walk distance predicts VO
2014, '[Updated treatment algorithm of pulmonary arterial hypertension].', Turk Kardiyol Dern Ars, 42 Suppl 1, pp. 78 - 94, https://www.ncbi.nlm.nih.gov/pubmed/25697036
,2014, 'Factors Influencing Waiting Time on the Heart Transplant Waiting List in Australia and New Zealand', The Journal of Heart and Lung Transplantation, 33, pp. S262 - S262, http://dx.doi.org/10.1016/j.healun.2014.01.915
,2014, 'Long-term Riociguat Treatment in PAH Patients in WHO Functional Class (FC) I/II Versus FC III/IV at Baseline: Results From the 12-Week Phase III PATENT-1 Study and PATENT-2 Open-Label Extension', Chest, 145, pp. 513A - 513A, http://dx.doi.org/10.1378/chest.1824389
,2014, 'O140 Pulmoaary Hypertension in Adult Congenital Heart Disease – The ANZ PAH-CHD Registry', Global Heart, 9, pp. e38 - e38, http://dx.doi.org/10.1016/j.gheart.2014.03.1349
,2013, 'Comparison of hemodynamic parameters in treatment-naive and pretreated patients with pulmonary arterial hypertension (PAH) in the Phase III PATENT-1 study', European Heart Journal, 34, pp. P323 - P323, http://dx.doi.org/10.1093/eurheartj/eht307.p323
,2013, 'Riociguat for the Treatment of Pulmonary Arterial Hypertension', New England Journal of Medicine, 369, pp. 330 - 340, http://dx.doi.org/10.1056/NEJMoa1209655
,2013, 'Functional Characterization of a Novel Mutation in NKX2-5 Associated With Congenital Heart Disease and Adult-Onset Cardiomyopathy', Circulation: Cardiovascular Genetics, 6, pp. 238 - 247, http://dx.doi.org/10.1161/CIRCGENETICS.113.000057
,2013, 'Everolimus versus mycophenolate mofetil in heart transplantation: A randomized, multicenter trial', American Journal of Transplantation, 13, pp. 1203 - 1216, http://dx.doi.org/10.1111/ajt.12181
,2013, 'Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients', Am J Transplant, 13, pp. 174 - 183, http://dx.doi.org/10.1111/j.1600-6143.2012.04302.x
,2013, 'Continuous Flow Left Ventricular Assist Devices Improve Survival in Reactive But Not Fixed Type 2 Pulmonary Hypertension', Heart, Lung and Circulation, 22, pp. S73 - S73, http://dx.doi.org/10.1016/j.hlc.2013.05.175
,2013, 'Death on an LVAD—Two Sides of a Coin', Heart, Lung and Circulation, 22, pp. 952 - 954, http://dx.doi.org/10.1016/j.hlc.2013.02.001
,2013, 'Effect of Body Position on Continuous Flow Left Ventricular Assist Device Flow Dynamics', Heart, Lung and Circulation, 22, pp. S76, http://dx.doi.org/10.1016/j.hlc.2013.05.180
,2013, 'Effect of the HeartWare HVAD Continuous-flow Left Ventricular Assist Device on Clinical Outcomes', Heart, Lung and Circulation, 22, pp. S76, http://dx.doi.org/10.1016/j.hlc.2013.05.181
,2013, 'Impact of Implantable Cardioverter Defibrillators on Survival of Patients with Centrifugal Left Ventricular Assist Devices', Heart, Lung and Circulation, 22, pp. S79, http://dx.doi.org/10.1016/j.hlc.2013.05.188
,2013, 'Increased incidence of angiodysplasia of the gastrointestinal tract and bleeding in patients with continuous flow left ventricular assist devices (LVADs)', The International Journal of Artificial Organs, 36, pp. 449 - 454, http://dx.doi.org/10.5301/ijao.5000224
,2013, 'Intracranial Haemorrhagic Events with Continuous-Flow Centrifugal Left Ventricular Assist Devices: A Tertiary Centre Experience', Heart, Lung and Circulation, 22, pp. S205, http://dx.doi.org/10.1016/j.hlc.2013.05.487
,2013, 'Non-invasive Determination of the Preload Recruitable Stroke Work Relationship in Patients with Heart Failure', Heart, Lung and Circulation, 22, pp. S84, http://dx.doi.org/10.1016/j.hlc.2013.05.200
,2013, 'Regarding "A process-based review of mouse models of pulmonary hypertension"', Pulmonary Circulation, 3, pp. 447 - 447, http://dx.doi.org/10.4103/2045-8932.114782
,2013, 'Riociguat for the Treatment of Pulmonary Arterial Hypertension (PAH): 1-Year Results from the PATENT-2 Long-term Extension Study', Chest, 144, pp. 1024A - 1024A, http://dx.doi.org/10.1378/chest.1783307
,2013, 'Tenckhoff Catheter Implantation and Modified Peritoneal Dialysis As a Novel Therapeutic Approach in Diuretic Resistant Congestive Heart Failure: A Single-centre Case-series', Heart, Lung and Circulation, 22, pp. S89, http://dx.doi.org/10.1016/j.hlc.2013.05.211
,2013, 'Time from symptoms to definitive diagnosis of idiopathic pulmonary arterial hypertension: The delay study', Pulmonary Circulation, 3, pp. 89 - 94, http://dx.doi.org/10.4103/2045-8932.109919
,2013, 'Updated Treatment Algorithm of Pulmonary Arterial Hypertension', Journal of the American College of Cardiology, 62, pp. D60 - D72, http://dx.doi.org/10.1016/j.jacc.2013.10.031
,2012, 'The study of risk in pulmonary arterial hypertension', European Respiratory Review, 21, pp. 234 - 238, http://dx.doi.org/10.1183/09059180.00003712
,